Knapp CP, Chandler DJ, Keck TM, Boateng CA, Floresco SB, Waterhouse BD, Navarra RL. Novel dopamine D4 receptor ligands differentially shape psychostimulant-induced risky choice preference without altering baseline decision making in rodents.
American College of Neuropsychopharmacology, 2026
54th Annual Meeting for the Society for Neuroscience, 2025
Knapp CP*, Fox DP, Waterhouse BD, Navarra RL. Effects of repetitive mild traumatic brain injury and methylphenidate treatment on cognitive flexibility in rodents.
54th Annual Meeting for the Society for Neuroscience.***Trainee Professional Development Award Recipient, 2025
National Neurotrauma Society, 2025
Philadelphia Chapter of the Society for Neuroscience, 2025
Papadopoulos E, Walkow S, Abrimian A, Knapp CP, Loweth JA, Waterhouse BD, Navarra RL. Sex-differences in Risk/Reward Decision Making Following Therapeutic Doses of Methylphenidate and Repetitive Mild Traumatic Brain Injury in Rodents.
National Neurotrauma Society, 2025
Papadopoulos E, Walkow S, Abrimian A, Knapp CP, Loweth JA, Waterhouse BD, Navarra RL. Therapeutic doses of methylphenidate following repetitive mild traumatic brain injury transiently disrupts risk/reward decision making in a sex dependent manner.
American Physician Scientists Association Northeast Regional Meeting, 2025
Abrimian A*, Papadopoulos E, Knapp CP, Loweth JA, Waterhouse BD, Navarra RL. Catecholamine transporter protein levels within the rodent prefrontal cortex are altered by the interactions between repetitive mild traumatic brain injury and methylphenidate administration in a sex-dependent manner.
Association of Academic Psychiatrists Annual Meeting, 2025
Walkow S, Ivak NA, Chandler D, Tkaczynski J, Keck TM, Boateng CA, Papadopoulos E, Waterhouse BD, Navarra RL. Effects of novel dopamine D4 receptor-targeted compounds on locomotor activity and anxiety-like behavior in male and female Sprague Dawley rats.
Mid-Atlantic Pharmacology Society 2024
Ivak NA, Walkow S, Knapp CP, Papadopoulos E, Waterhouse BD, Navarra RL. Effects of the non-stimulant norepinephrine reuptake inhibitor, atomoxetine, on cognitive flexibility in healthy adult Long-Evans rats.
Mid-Atlantic Pharmacology Society, 2024
Navarra RL, Knapp CP, Papadopoulos E, Abrimian A, Waterhouse BD. Featured Speaker: Psychostimulant actions on executive dysfunction and prefrontal catecholamine dysregulation following traumatic brain injury.
Conference on Cognitive and Behavioral Neurosciences ***Invited Speaker, 2024
Knapp CP, Papadopoulos E, Loweth JA, Raghupathi R, Floresco SB, Waterhouse BD, Navarra RL. Perturbations in risk/reward decision making and frontal cortical catecholamine regulation induced by mild traumatic brain injury.
53rd Annual Meeting for the Society for Neuroscience, 2024
Papadopoulos E, Abrimian A, Knapp CP, Joyce K, Waterhouse BD, Navarra RL. Sex-dependent restoration of risky decision making and prefrontal catecholamine regulatory proteins using low-dose methylphenidate following repeated mild traumatic brain injury.
53rd Annual Meeting for the Society for Neuroscience, 2024
Knapp CP, Papadopoulos E, Loweth JA, Raghupathi R, Floresco SB, Waterhouse BD, Navarra RL. Perturbations in risk/reward decision making and frontal cortical catecholamine regulation induced by mild traumatic brain injury.
Philadelphia Chapter of the Society for Neuroscience, 2024
Papadopoulos E*, Abrimian A, Knapp CP, Joyce K, Waterhouse BD, Navarra RL. Low dose methylphenidate modulates risky decision making and prefrontal catecholamine regulation in a sex-dependent manner following repeated mild traumatic brain injury.
Philadelphia Chapter of the Society for Neuroscience***1st Place in Graduate Student Poster Competition, 2024
Abrimian A*, Papadopoulos E, Knapp CP, Loweth JA, Waterhouse BD, Navarra RL. Interactions between repetitive mild traumatic brain injury and methylphenidate administration on catecholamine transporter protein levels within the rodent prefrontal cortex.
American Academy of Neurology Annual Meeting***Future in Neurologic Research Scholarship Travel Awardee, 2024
Navarra RL*, Papadopoulos E, Abrimian A, Knapp CP, Loweth J, Floresco S, Waterhouse BD. Sex-dependent modulation of executive function and catecholamine regulation with psychostimulant treatment following repetitive mild traumatic brain injury.
International Behavioral Neuroscience Society***Symposium Chair and Speaker, 2024
Knapp CP, Papadopoulos E, Loweth JA, Raghupathi R, Floresco SB, Waterhouse BD, Navarra RL. Perturbations in risk/reward decision making and frontal cortical catecholamine regulation induced by mild traumatic brain injury.
International Behavioral Neuroscience Society, 2024
Papadopoulos E*, Abrimian A, Knapp CP, Joyce K, Waterhouse BD, Navarra RL. Low dose methylphenidate modulates risky decision making and prefrontal catecholamine regulation in a sex-dependent manner following repeated mild traumatic brain injury.
International Behavioral Neuroscience Society***IBNS Travel Awardee, 2024
American Society for Pharmacology and Experimental Therapeutics Annual Meeting***ASPET Travel Awardee, 2024
Knapp CP, Papadopoulos E, Floresco SB, Waterhouse BD, Navarra RL. Sex differences in risk/reward decision making and prefrontal catecholamine regulation following repetitive mild traumatic brain injury.
53rd Annual Meeting for the Society for Neuroscience, 2023
Papadopoulos E*, Abrimian A, Knapp CP, Joyce K, Waterhouse BD, Navarra RL. Low dose methylphenidate counteracts increased risky decision making following repetitive mild traumatic brain injury in female rodents.
53rd Annual Meeting for the Society for Neuroscience***Diversity Poster Session, 3rd Place in Bioss Antibodies Neuroscience Grant, 2023
Knapp CP*, Papadopoulos E, Floresco SB, Waterhouse BD, Navarra RL. Sex differences in risk/reward decision making and prefrontal catecholamine regulation following repetitive mild traumatic brain injury.
Annual Biomedical Research Conference for Minoritized Scientists***ABRCMS Travel Awardee, 2023
Navarra RL*, Papadopoulos E, Abrimian A, Knapp CP, Loweth J, Floresco S, Waterhouse BD. A novel platform for targeting treatment of prefrontal catecholamine dysregulation and executive dysfunction following traumatic brain injury.
Abrimian A, Papadopoulos E, Knapp CP, Loweth JA, Waterhouse BD, Navarra RL. Interactions between repetitive mild traumatic brain injury and methylphenidate administration on catecholamine transporter protein levels within the rodent prefrontal cortex.
Mid-Atlantic Pharmacology Society, 2023
Papadopoulos E*, Abrimian A, Knapp CP, Joyce K, Waterhouse BD, Navarra RL. Low dose methylphenidate counteracts increased risky decision making following repetitive mild traumatic brain injury in female rodents.
Mid-Atlantic Pharmacology Society***2nd Place in Graduate Student Poster Competition, 2023
Knapp CP*, Papadopoulos E, Floresco SB, Waterhouse BD, Navarra RL. Sex differences in risk/reward decision making and prefrontal catecholamine regulation following repetitive mild traumatic brain injury.
National Neurotrauma Society***NNS Diversity Travel Awardee, 2023
Navarra RL, Knapp CP, Papadopoulos E, Loweth J, Corbett C, Floresco SB, Raghupathi R, Waterhouse BD. Executive functions and catecholamine regulatory protein levels within the prefrontal cortex following repetitive mild traumatic brain injury.
International Behavioral Neuroscience Society, 2023
Navarra RL, Knapp CP, Papadopoulos E, Loweth J, Corbett C, Floresco SB, Raghupathi R, Waterhouse BD. Executive functions and catecholamine regulatory protein levels within the prefrontal cortex following repetitive mild traumatic brain injury.
Gordon Research Conference: Catecholamines, 2023
Knapp CP, Papadopoulos E, Loweth JA, Corbett CM, Floresco SB, Waterhouse BD, Navarra RL. Sex-specific variation of catecholamine regulatory proteins may underlie increased risky choice preference following repetitive mild traumatic brain injury.
51st Annual Meeting for the Society for Neuroscience, 2022
National Neurotrauma Society, 2022
International Behavioral Neuroscience Society, 2022
Navarra RL, Knapp CP, Papadopoulos E, Loweth J, Corbett C, Floresco SB, Raghupathi R, Waterhouse BD. Cognitive flexibility, risk/reward decision making, and catecholamine regulatory proteins within the prefrontal cortex following repetitive mild traumatic brain injury.
International Behavioral Neuroscience Society*** Symposium Chair and Speaker, 2022
Papadopoulos E, Knapp CP, Corbett C, Loweth JA, Navarra RL. Examining levels of catecholamine neurotransmitter regulatory proteins within the prefrontal cortex of rodents following traumatic brain injury.
American Osteopathic Association OMED Research*** 1st prize in Student Research Competition, 2022
National Student Osteopathic Medical Association Research Symposium*** 1st prize in Basic Science Competition, 2021
Knapp CP, Fallon B, Floresco SB, Kortagere S, Waterhouse BD, Navarra RL. SK609, a novel dopamine D3 receptor agonist and norepinephrine transporter blocker with pro-cognitive actions, does not induce psychostimulant-like increases in risky choice during probabilistic discounting.
Mid-Atlantic Pharmacology Society Annual Meeting. 2021
International Behavioral Neuroscience Society, 2020
Predale HK, Knapp CP, Raghupathi R, Waterhouse BD, Navarra RL. Physiological response and tissue damage following different depths of impact in a rodent model of mild traumatic brain injury.
50th Annual Meeting for the Society for Neuroscience, 2021
50th Annual Meeting for the Society for Neuroscience, 2021
International Behavioral Neuroscience Society, 2021
Navarra RL, Knapp CP, Fallon B, Kortagere, S, Waterhouse, BD, Floresco, SB. SK609, a novel dopamine D3 receptor agonist and norepinephrine transporter blocker with pro-cognitive actions, does not induce psychostimulant-like increases in risky choice during probabilistic discounting.
American College of Neuropsychopharmacology, 2020
Knapp CP, Fallon B, Fox DP, Floresco SB, Raghupathi R, Waterhouse BD, Navarra RL. Time course of deficit and recovery following repetitive traumatic brain injury in a rodent assay of cognitive flexibility.
Brain Injury Alliance of New Jersey Annual Seminar, 2020
American Brain Injury, Best Practices in Brain Injury Medicine and Neurorehabilitation: Improving Outcomes through Interdisciplinary Collaboration, 2020
Knapp CP, Fallon B, Fox DP, Floresco SB, Raghupathi R, Waterhouse BD, Navarra RL. Time course of deficit and recovery following repetitive traumatic brain injury in a rodent assay of cognitive flexibility.
Mid-Atlantic Pharmacology Society Annual Meeting, 2019
49th Annual Meeting for the Society for Neuroscience, 2019
Waterhouse BD, Navarra RL, Chandler DJ, Devilbiss DM, Joshi, N, Fox DP. Functional attributes of the rodent central norepinephrine transmitter system following repetitive mild traumatic brain injury.
49th Annual Meeting for the Society for Neuroscience, 2019
International Behavioral Neuroscience Society, 2019
Navarra RL, Knapp CP, Fox DP, Floresco SB, Waterhouse BD. Evaluating “productivity” vs “quality” of performance in rodent assays of cognitive function.
49th Annual Meeting for the Society for Neuroscience, 2019
International Behavioral Neuroscience Society, 2019
Knapp CP, Fox DP, Floresco SB, Giacometti LL, Raghupathi R, Waterhouse BD, Navarra RL. Repetitive mild traumatic brain injury impairs performance in a rodent assay of cognitive flexibility.
Philadelphia Chapter of Society for Neuroscience, 2019
48th Annual Meeting for the Society for Neuroscience, 2018
Knapp CP, Kuponiyi OG, Floresco SB, Waterhouse BD, Navarra RL. Methylphenidate enhances specific dimensions of cognitive performance in a rodent strategy shifting assay of cognitive flexibility.
48th Annual Meeting for the Society for Neuroscience, 2018
Philadelphia Chapter of Society for Neuroscience, 2018
Navarra RL, Clark BD, Waterhouse BD. Are psychostimulant-induced alterations of local field potentials within primary visual circuits related to signal detection performance?
Winter Conference on Brain Research*** Special Poster Award Session, 2017
Navarra RL, Clark BD, Waterhouse BD. Methylphenidate enhances early stage sensory signal processing within the rat during performance of a visual signal detection task.
46th Annual Meeting for the Society for Neuroscience, 2016
Navarra RL, Garguilo AT, Clark BD, Waterhouse BD. Methylphenidate enhances early sensory signal processing in the rat visual thalamus through noradrenergic signaling.
Winter Conference on Brain Research*** Special Poster Award Session, 2016
45th Annual Meeting for the Society for Neuroscience*** Neuroscience Hot Topic, 2015
Mitchell LR, Navarra RL, Clark BD, Waterhouse BD. Methylphenidate-induced enhancement of LFP responses to visual stimuli in rat sensory thalamus.
45th Annual Meeting for the Society for Neuroscience, 2015
Navarra RL, Garguilo AT, Clark BD, Waterhouse BD. Methylphenidate enhances early sensory signal processing in the rat visual thalamus through noradrenergic signaling.
Gordon Research Conference: Catecholamines, 2015
Navarra RL, Clark BD, Waterhouse BD. Psychostimulant-induced modulation of early sensory signal processing in the rat visual thalamus is mediated by enhance noradrenergic transmission.
Philadelphia Chapter of Society for Neuroscience, 2015
44th Annual Meeting for the Society for Neuroscience, 2014
Waterhouse BD, Navarra RL, Zitnik GA, Clark BD. Methylphenidate enhancement of early-stage sensory signal processing.
52nd Annual Meeting for the American College of Neuropsychopharmacology, 2013
Navarra RL, Clark BD, Waterhouse BD. Distinguishing the mechanisms underlying differential effects of attention enhancing compounds on early sensory signal processing in the rat visual thalamus.
43rd Annual Meeting for the Society for Neuroscience, 2013
Gordon Research Conference: Catecholamines, 2013
Navarra RL, Clark BD, Zitnik GA, Waterhouse BD. The effects of methylphenidate and atomoxetine on visually-evoked neuronal activity of the dorsal lateral geniculate nucleus in the rat.
42nd Annual Meeting for the Society for Neuroscience, 2012
Navarra RL, Kelley C, Graf R, Grauer SM, Aschmies S, Marquis KL, Robichaud A, Gross J, Brandon N, Comery TA. Characterization of the histamine H3 receptor antagonist WAY-364416 in models relevant to schizophrenia and interaction with antispsychotics.
39th Annual Meeting for the Society for Neuroscience, 2009
Dr. Navarra of Cell Biology & Neuroscience at TBES & Rowan-Virtua SOM